CMMB
Chemomab Therapeutics
CMMB
CMMB
5 hedge funds and large institutions have $1.29M invested in Chemomab Therapeutics in 2020 Q2 according to their latest regulatory filings, with 2 funds opening new positions, increasing their positions, 0 reducing their positions, and 1 closing their positions.
Holders
5
Holders Change
+1
Holders Change %
+25%
% of All Funds
0.1%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
–
Reduced
–
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
MIH
1
Meitav Investment House
Bene-Beraq,
Israel
|
$500K |
| 2 |
RC
2
RegentAtlantic Capital
Morristown,
New Jersey
|
$34K |
Top Sellers
| 1 |
1
UBS Group
Zurich,
Switzerland
|
$0 |
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
PCM
1
Palisade Capital Management
Fort Lee,
New Jersey
| $506K | 369,640 | – | – |
|
|
MIH
2
Meitav Investment House
Bene-Beraq,
Israel
| $500K | 364,646 | +364,646 | New |
|
|
AIC
3
AWM Investment Company
New York
| $217K | 158,123 | – | – |
|
|
PF
4
Phoenix Financial
Givatayim,
Israel
| $34K | 26,087 | – | – |
|
|
RC
5
RegentAtlantic Capital
Morristown,
New Jersey
| $34K | 25,000 | +25,000 | New |
|
|
6
UBS Group
Zurich,
Switzerland
| – | – | -2,183 | Closed |
|
|
CFGS
7
Concourse Financial Group Securities
Birmingham,
Alabama
| – | – | – | – |
|